Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100
Clinical trial NCT05684705 · COMPLETED
Trial details
- NCT number
- NCT05684705
- Sponsor
- BioVersys AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2024-10-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.